ZYNE had a 46% improvement with their CBD topical gel for infants in their Phase II exploratory clinical trial of 20 patients. It is a synthetic CBD analogue. Their stock rose over 52% on this news. Our cream has shown a 70% improvement for inflammatory markers in psoriasis for our Phase I trial. Just wait until we publish our results. Hold on to your hats folks.

https://seekingalpha.com/news/3298091-zynerba...96-percent